25 XP   0   0   10

Tianjin Chase Sun Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Tianjin Chase Sun Pharmaceutical Co Ltd together

PenkeI guess you are interested in Tianjin Chase Sun Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tianjin Chase Sun Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tianjin Chase Sun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Tianjin Chase Sun Pharmaceutical Co Ltd.

Quick analysis of Tianjin Chase Sun Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Tianjin Chase Sun Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥2.95
Expected worth in 1 year
¥3.09
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.22
Return On Investment
5.9%

For what price can you sell your share?

Current Price per Share
¥3.69
Expected price per share
¥3.07 - ¥3.84
How sure are you?
50%

1. Valuation of Tianjin Chase Sun Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥3.69

Intrinsic Value Per Share

¥1.61 - ¥4.33

Total Value Per Share

¥4.57 - ¥7.28

2. Growth of Tianjin Chase Sun Pharmaceutical Co Ltd (5 min.)




Is Tianjin Chase Sun Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$1.1b$67.4m5.6%

How much money is Tianjin Chase Sun Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$17.5m$21.5m-$4m-23.2%
Net Profit Margin7.7%9.3%--

How much money comes from the company's main activities?

3. Financial Health of Tianjin Chase Sun Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Tianjin Chase Sun Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Tianjin Chase Sun Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Tianjin Chase Sun Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Tianjin Chase Sun Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Tianjin Chase Sun Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tianjin Chase Sun Pharmaceutical Co Ltd is ¥3.69. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tianjin Chase Sun Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tianjin Chase Sun Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.95. Based on the TTM, the Book Value Change Per Share is ¥0.03 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tianjin Chase Sun Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.010.2%0.010.2%0.010.2%0.010.2%
Usd Book Value Change Per Share0.000.0%0.000.1%0.010.2%0.010.1%0.010.2%
Usd Dividend Per Share0.000.0%0.000.1%0.000.1%0.000.1%0.000.1%
Usd Total Gains Per Share0.000.0%0.010.2%0.010.2%0.010.2%0.010.3%
Usd Price Per Share0.59-0.70-0.92-0.70-1.39-
Price to Earnings Ratio-1,248.59--294.32-34.20--46.10-22.53-
Price-to-Total Gains Ratio-3,189.49--741.05-110.53--116.28-36.17-
Price to Book Ratio1.44-1.73-2.41-1.95-8.12-
Price-to-Total Gains Ratio-3,189.49--741.05-110.53--116.28-36.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.509958
Number of shares1960
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (1960 shares)14.6214.54
Gains per Year (1960 shares)58.4858.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1223648174148
244731063483106
36610916451124164
48814622267165222
511018228084207280
6132219338101248338
7154255396118289396
8176292454135331454
9198328512152372512
10220365570168413570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%17.03.00.085.0%35.04.01.087.5%53.04.01.091.4%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%35.05.00.087.5%52.06.00.089.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%54.00.04.093.1%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%17.03.00.085.0%36.04.00.090.0%53.05.00.091.4%

Fundamentals of Tianjin Chase Sun Pharmaceutical Co Ltd

About Tianjin Chase Sun Pharmaceutical Co Ltd

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China and internationally. The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, healthcare services, and smart supply chain for pharmaceutical and medical devices. It provides its products in the areas of severe disease, cardiovascular, cerebrovascular system, respiratory system, neurodegenerative, and anti-tumor. The company was founded in 1996 and is based in Tianjin, China.

Fundamental data was last updated by Penke on 2024-04-16 11:32:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Tianjin Chase Sun Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tianjin Chase Sun Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -0.2% means that ¥0.00 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is -0.2%. The company is not making a profit/loss.
  • The TTM is 7.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM7.7%-7.9%
TTM7.7%YOY9.3%-1.6%
TTM7.7%5Y8.8%-1.1%
5Y8.8%10Y11.4%-2.5%
1.1.2. Return on Assets

Shows how efficient Tianjin Chase Sun Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Assets means that Tianjin Chase Sun Pharmaceutical Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.0%TTM1.0%-1.0%
TTM1.0%YOY1.3%-0.3%
TTM1.0%5Y1.3%-0.3%
5Y1.3%10Y1.8%-0.5%
1.1.3. Return on Equity

Shows how efficient Tianjin Chase Sun Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Tianjin Chase Sun Pharmaceutical Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 1.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM1.5%-1.5%
TTM1.5%YOY1.9%-0.4%
TTM1.5%5Y1.8%-0.4%
5Y1.8%10Y2.3%-0.5%

1.2. Operating Efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tianjin Chase Sun Pharmaceutical Co Ltd is operating .

  • Measures how much profit Tianjin Chase Sun Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.6%-2.6%
TTM2.6%YOY11.0%-8.3%
TTM2.6%5Y9.6%-7.0%
5Y9.6%10Y5.6%+4.0%
1.2.2. Operating Ratio

Measures how efficient Tianjin Chase Sun Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are ¥1.49 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 1.488. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.365. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.488TTM1.365+0.123
TTM1.365YOY1.297+0.067
TTM1.3655Y1.285+0.080
5Y1.28510Y0.817+0.468

1.3. Liquidity of Tianjin Chase Sun Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tianjin Chase Sun Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.29 means the company has ¥4.29 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 4.294. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.676. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.294TTM3.676+0.618
TTM3.676YOY3.061+0.615
TTM3.6765Y3.325+0.351
5Y3.32510Y2.018+1.308
1.3.2. Quick Ratio

Measures if Tianjin Chase Sun Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.74 means the company can pay off ¥1.74 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 1.740. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.576. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.740TTM1.576+0.164
TTM1.576YOY1.541+0.034
TTM1.5765Y1.588-0.012
5Y1.58810Y1.703-0.115

1.4. Solvency of Tianjin Chase Sun Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tianjin Chase Sun Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.25 means that Tianjin Chase Sun Pharmaceutical Co Ltd assets are financed with 25.1% credit (debt) and the remaining percentage (100% - 25.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 0.251. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.287. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.251TTM0.287-0.036
TTM0.287YOY0.312-0.025
TTM0.2875Y0.257+0.030
5Y0.25710Y0.210+0.047
1.4.2. Debt to Equity Ratio

Measures if Tianjin Chase Sun Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 34.1% means that company has ¥0.34 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The MRQ is 0.341. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.412. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.341TTM0.412-0.071
TTM0.412YOY0.463-0.051
TTM0.4125Y0.364+0.048
5Y0.36410Y0.282+0.082

2. Market Valuation of Tianjin Chase Sun Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tianjin Chase Sun Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Tianjin Chase Sun Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1,248.59 means the investor is paying ¥-1,248.59 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The EOD is -1,086.625. Based on the earnings, the company is expensive. -2
  • The MRQ is -1,248.588. Based on the earnings, the company is expensive. -2
  • The TTM is -294.321. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1,086.625MRQ-1,248.588+161.963
MRQ-1,248.588TTM-294.321-954.267
TTM-294.321YOY34.205-328.526
TTM-294.3215Y-46.097-248.224
5Y-46.09710Y22.525-68.622
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The EOD is 8.084. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.289. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 24.014. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD8.084MRQ9.289-1.205
MRQ9.289TTM24.014-14.724
TTM24.014YOY-898.649+922.663
TTM24.0145Y-180.072+204.086
5Y-180.07210Y-834.458+654.386
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tianjin Chase Sun Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tianjin Chase Sun Pharmaceutical Co Ltd:

  • The EOD is 1.250. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.436. Based on the equity, the company is underpriced. +1
  • The TTM is 1.733. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.250MRQ1.436-0.186
MRQ1.436TTM1.733-0.297
TTM1.733YOY2.414-0.681
TTM1.7335Y1.945-0.212
5Y1.94510Y8.115-6.170
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tianjin Chase Sun Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0040.034-113%0.042-110%0.038-112%0.060-107%
Book Value Per Share--2.9522.922+1%2.759+7%2.604+13%2.134+38%
Current Ratio--4.2943.676+17%3.061+40%3.325+29%2.018+113%
Debt To Asset Ratio--0.2510.287-13%0.312-20%0.257-2%0.210+19%
Debt To Equity Ratio--0.3410.412-17%0.463-26%0.364-6%0.282+21%
Dividend Per Share--0.0030.020-85%0.023-87%0.016-80%0.015-79%
Eps---0.0010.042-102%0.052-102%0.046-102%0.042-102%
Free Cash Flow Per Share--0.1140.098+16%-0.002+102%0.002+5131%0.006+1720%
Free Cash Flow To Equity Per Share--0.1140.062+83%-0.029+125%0.006+1857%0.043+165%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--4.330--------
Intrinsic Value_10Y_min--1.614--------
Intrinsic Value_1Y_max--0.146--------
Intrinsic Value_1Y_min--0.049--------
Intrinsic Value_3Y_max--0.658--------
Intrinsic Value_3Y_min--0.245--------
Intrinsic Value_5Y_max--1.434--------
Intrinsic Value_5Y_min--0.548--------
Market Cap11085313559.040-15%12737616508.88015186002701.035-16%19962608891.865-36%15277333347.459-17%30170595403.859-58%
Net Profit Margin---0.0020.077-103%0.093-102%0.088-102%0.114-102%
Operating Margin---0.026-100%0.110-100%0.096-100%0.056-100%
Operating Ratio--1.4881.365+9%1.297+15%1.285+16%0.817+82%
Pb Ratio1.250-15%1.4361.733-17%2.414-40%1.945-26%8.115-82%
Pe Ratio-1086.625+13%-1248.588-294.321-76%34.205-3750%-46.097-96%22.525-5643%
Price Per Share3.690-15%4.2405.055-16%6.645-36%5.083-17%10.042-58%
Price To Free Cash Flow Ratio8.084-15%9.28924.014-61%-898.649+9774%-180.072+2038%-834.458+9083%
Price To Total Gains Ratio-2775.759+13%-3189.490-741.048-77%110.533-2986%-116.279-96%36.166-8919%
Quick Ratio--1.7401.576+10%1.541+13%1.588+10%1.703+2%
Return On Assets--0.0000.010-102%0.013-102%0.013-102%0.018-101%
Return On Equity--0.0000.015-102%0.019-102%0.018-102%0.023-101%
Total Gains Per Share---0.0010.054-102%0.066-102%0.054-102%0.075-102%
Usd Book Value--1225524798.1651212993783.560+1%1145561318.931+7%1081615133.502+13%886107463.447+38%
Usd Book Value Change Per Share---0.0010.005-113%0.006-110%0.005-112%0.008-107%
Usd Book Value Per Share--0.4080.404+1%0.381+7%0.360+13%0.295+38%
Usd Dividend Per Share--0.0000.003-85%0.003-87%0.002-80%0.002-79%
Usd Eps--0.0000.006-102%0.007-102%0.006-102%0.006-102%
Usd Free Cash Flow--47375379.56340871672.966+16%-861177.888+102%899432.702+5167%2599816.846+1722%
Usd Free Cash Flow Per Share--0.0160.014+16%0.000+102%0.000+5131%0.001+1720%
Usd Free Cash Flow To Equity Per Share--0.0160.009+83%-0.004+125%0.001+1857%0.006+165%
Usd Market Cap1531990333.859-15%1760338601.5272098705573.283-16%2758832548.856-36%2111327468.619-17%4169576284.813-58%
Usd Price Per Share0.510-15%0.5860.699-16%0.918-36%0.702-17%1.388-58%
Usd Profit---352465.90217504115.758-102%21565455.988-102%19306906.233-102%17607406.799-102%
Usd Revenue--163963289.194211060928.127-22%229758359.685-29%220570371.914-26%171358569.537-4%
Usd Total Gains Per Share--0.0000.007-102%0.009-102%0.007-102%0.010-102%
 EOD+4 -4MRQTTM+16 -19YOY+15 -205Y+15 -2010Y+14 -22

3.2. Fundamental Score

Let's check the fundamental score of Tianjin Chase Sun Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1,086.625
Price to Book Ratio (EOD)Between0-11.250
Net Profit Margin (MRQ)Greater than0-0.002
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.740
Current Ratio (MRQ)Greater than14.294
Debt to Asset Ratio (MRQ)Less than10.251
Debt to Equity Ratio (MRQ)Less than10.341
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Tianjin Chase Sun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.848
Ma 20Greater thanMa 503.840
Ma 50Greater thanMa 1003.868
Ma 100Greater thanMa 2004.056
OpenGreater thanClose3.660
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Income  153,68821,765175,454-5,034170,420-7,112163,308-165,859-2,550
Net Income from Continuing Operations  151,48727,305178,792-7,853170,939-8,707162,232-172,628-10,396



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets11,835,032
Total Liabilities2,967,269
Total Stockholder Equity8,710,064
 As reported
Total Liabilities 2,967,269
Total Stockholder Equity+ 8,710,064
Total Assets = 11,835,032

Assets

Total Assets11,835,032
Total Current Assets6,720,238
Long-term Assets5,114,793
Total Current Assets
Cash And Cash Equivalents 1,573,637
Net Receivables 2,722,728
Inventory 1,960,860
Other Current Assets 109,907
Total Current Assets  (as reported)6,720,238
Total Current Assets  (calculated)6,367,132
+/- 353,107
Long-term Assets
Property Plant Equipment 3,242,124
Goodwill 692,537
Intangible Assets 672,543
Long-term Assets Other 24,966
Long-term Assets  (as reported)5,114,793
Long-term Assets  (calculated)4,632,169
+/- 482,624

Liabilities & Shareholders' Equity

Total Current Liabilities1,564,848
Long-term Liabilities1,402,421
Total Stockholder Equity8,710,064
Total Current Liabilities
Short Long Term Debt 23,175
Accounts payable 713,452
Other Current Liabilities 23,659
Total Current Liabilities  (as reported)1,564,848
Total Current Liabilities  (calculated)760,287
+/- 804,561
Long-term Liabilities
Long term Debt 1,257,245
Capital Lease Obligations Min Short Term Debt59,419
Long-term Liabilities  (as reported)1,402,421
Long-term Liabilities  (calculated)1,316,664
+/- 85,758
Total Stockholder Equity
Retained Earnings 4,828,785
Total Stockholder Equity (as reported)8,710,064
Total Stockholder Equity (calculated)4,828,785
+/- 3,881,279
Other
Capital Stock3,004,155
Common Stock Shares Outstanding 3,004,155
Net Invested Capital 9,990,484
Net Working Capital 5,155,391
Property Plant and Equipment Gross 3,242,124



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302008-12-312007-12-312006-12-31
> Total Assets 
105,618
175,028
217,140
246,998
275,138
1,061,777
1,048,828
1,154,669
1,185,159
1,279,823
1,325,571
1,326,306
1,304,874
1,407,469
1,453,978
1,578,426
1,629,352
1,801,820
1,862,554
1,970,072
2,049,344
2,218,992
2,454,569
2,655,237
2,890,535
3,043,409
4,129,636
4,140,597
4,345,938
6,472,574
6,764,680
6,682,216
7,263,218
7,281,311
7,340,333
7,302,111
7,386,955
7,428,215
7,563,704
7,778,898
7,737,502
7,483,638
7,665,007
8,108,745
8,308,131
8,426,545
9,133,379
9,702,170
10,075,895
10,179,628
10,549,640
10,527,329
11,478,789
11,607,301
11,756,400
11,798,131
11,995,272
12,630,857
12,610,188
12,446,675
12,378,128
11,835,032
11,835,03212,378,12812,446,67512,610,18812,630,85711,995,27211,798,13111,756,40011,607,30111,478,78910,527,32910,549,64010,179,62810,075,8959,702,1709,133,3798,426,5458,308,1318,108,7457,665,0077,483,6387,737,5027,778,8987,563,7047,428,2157,386,9557,302,1117,340,3337,281,3117,263,2186,682,2166,764,6806,472,5744,345,9384,140,5974,129,6363,043,4092,890,5352,655,2372,454,5692,218,9922,049,3441,970,0721,862,5541,801,8201,629,3521,578,4261,453,9781,407,4691,304,8741,326,3061,325,5711,279,8231,185,1591,154,6691,048,8281,061,777275,138246,998217,140175,028105,618
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,039,328
3,964,973
3,912,330
4,022,003
4,206,377
4,317,069
4,326,201
4,973,938
5,479,588
5,780,896
5,714,108
5,913,464
5,842,868
6,762,576
6,806,263
6,973,464
6,822,816
6,883,832
7,385,341
7,384,022
7,217,271
7,197,878
6,720,238
6,720,2387,197,8787,217,2717,384,0227,385,3416,883,8326,822,8166,973,4646,806,2636,762,5765,842,8685,913,4645,714,1085,780,8965,479,5884,973,9384,326,2014,317,0694,206,3774,022,0033,912,3303,964,9734,039,328000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,553,834
1,408,216
1,208,525
1,130,959
1,187,174
1,085,955
987,969
1,363,315
1,205,347
987,153
1,125,777
1,161,530
992,173
1,643,033
1,315,965
1,210,583
1,121,448
976,262
1,206,227
1,300,346
1,162,021
1,567,242
1,573,637
1,573,6371,567,2421,162,0211,300,3461,206,227976,2621,121,4481,210,5831,315,9651,643,033992,1731,161,5301,125,777987,1531,205,3471,363,315987,9691,085,9551,187,1741,130,9591,208,5251,408,2161,553,834000000000000000000000000000000000000000
       Net Receivables 
31,759
20,703
7,039
16,670
16,217
12,241
18,940
67,275
95,014
91,524
130,055
147,869
175,288
201,070
207,322
295,275
338,446
368,431
405,958
511,045
533,073
686,341
673,650
825,241
960,477
1,037,756
1,132,799
1,291,782
1,547,957
1,804,011
1,905,586
1,834,258
2,072,124
2,007,164
1,943,134
1,772,269
1,748,994
1,770,687
1,690,804
1,698,959
1,758,066
1,952,007
1,761,860
1,840,534
1,966,886
2,229,593
2,381,940
2,629,287
3,062,467
2,896,673
2,901,145
3,061,303
3,340,557
3,752,797
3,682,483
3,506,972
3,496,187
3,372,289
3,128,854
3,450,797
2,985,596
2,722,728
2,722,7282,985,5963,450,7973,128,8543,372,2893,496,1873,506,9723,682,4833,752,7973,340,5573,061,3032,901,1452,896,6733,062,4672,629,2872,381,9402,229,5931,966,8861,840,5341,761,8601,952,0071,758,0661,698,9591,690,8041,770,6871,748,9941,772,2691,943,1342,007,1642,072,1241,834,2581,905,5861,804,0111,547,9571,291,7821,132,7991,037,756960,477825,241673,650686,341533,073511,045405,958368,431338,446295,275207,322201,070175,288147,869130,05591,52495,01467,27518,94012,24116,21716,6707,03920,70331,759
       Other Current Assets 
2,178
3,786
7,802
4,597
5,508
2,969
7,015
15,218
19,740
2,033
16,341
17,071
6,413
5,546
5,515
6,385
24,601
20,651
17,834
18,242
20,965
10,744
18,544
23,484
33,224
26,741
30,672
49,789
60,411
49,134
78,294
85,950
109,593
111,870
168,101
141,686
184,947
148,138
161,619
148,005
155,305
110,809
47,749
61,690
75,906
168,858
253,822
348,877
388,837
257,707
390,534
407,791
474,407
416,221
544,254
461,711
562,220
160,184
154,288
329,027
96,155
109,907
109,90796,155329,027154,288160,184562,220461,711544,254416,221474,407407,791390,534257,707388,837348,877253,822168,85875,90661,69047,749110,809155,305148,005161,619148,138184,947141,686168,101111,870109,59385,95078,29449,13460,41149,78930,67226,74133,22423,48418,54410,74420,96518,24217,83420,65124,6016,3855,5155,5466,41317,07116,3412,03319,74015,2187,0152,9695,5084,5977,8023,7862,178
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,643,004
3,902,368
3,991,062
4,100,345
4,159,442
4,222,582
4,294,999
4,465,520
4,636,175
4,684,460
4,716,213
4,801,037
4,782,936
4,975,315
5,111,440
5,245,516
5,226,166
5,229,404
5,180,250
5,114,793
5,114,7935,180,2505,229,4045,226,1665,245,5165,111,4404,975,3154,782,9364,801,0374,716,2134,684,4604,636,1754,465,5204,294,9994,222,5824,159,4424,100,3453,991,0623,902,3683,643,004000000000000000000000000000000000000000000
       Property Plant Equipment 
41,215
45,370
84,021
108,814
102,653
120,887
112,896
152,612
159,195
208,229
218,026
321,928
307,961
390,784
391,457
451,340
463,380
702,067
678,045
705,571
693,434
731,166
711,893
716,741
729,285
749,146
751,947
764,679
805,279
1,125,687
1,215,038
1,269,833
1,273,349
1,373,897
1,426,293
1,470,040
1,500,638
1,576,360
1,580,400
1,736,595
1,758,581
1,802,952
1,795,079
1,941,426
2,001,056
2,306,375
2,336,874
2,407,351
2,444,752
2,556,089
2,680,970
2,685,945
2,723,355
2,901,286
2,910,326
2,971,361
3,089,075
3,321,878
3,335,110
3,312,520
3,277,134
3,242,124
3,242,1243,277,1343,312,5203,335,1103,321,8783,089,0752,971,3612,910,3262,901,2862,723,3552,685,9452,680,9702,556,0892,444,7522,407,3512,336,8742,306,3752,001,0561,941,4261,795,0791,802,9521,758,5811,736,5951,580,4001,576,3601,500,6381,470,0401,426,2931,373,8971,273,3491,269,8331,215,0381,125,687805,279764,679751,947749,146729,285716,741711,893731,166693,434705,571678,045702,067463,380451,340391,457390,784307,961321,928218,026208,229159,195152,612112,896120,887102,653108,81484,02145,37041,215
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,437
14,437
14,437
14,437
14,437
14,437
14,437
1,293,324
1,295,770
1,301,971
1,301,971
1,301,971
1,301,971
1,301,971
1,301,971
1,177,762
1,177,762
1,177,106
1,177,106
918,878
918,878
921,767
922,397
799,178
799,178
799,178
799,178
799,178
799,178
799,178
799,178
716,052
716,052
716,052
716,052
716,052
716,052
716,052
716,052
692,537
692,537716,052716,052716,052716,052716,052716,052716,052716,052799,178799,178799,178799,178799,178799,178799,178799,178922,397921,767918,878918,8781,177,1061,177,1061,177,7621,177,7621,301,9711,301,9711,301,9711,301,9711,301,9711,301,9711,295,7701,293,32414,43714,43714,43714,43714,43714,43714,4370000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
281,177
281,551
281,524
296,038
319,671
303,033
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000303,033319,671296,038281,524281,551281,177000000000000000000000000000000000000000
       Intangible Assets 
16,894
20,701
27,096
9,929
26,440
9,587
42,950
38,176
83,449
38,704
80,052
37,122
97,623
35,561
99,181
34,028
102,316
35,096
105,397
33,742
110,658
32,523
70,725
70,097
127,321
127,480
126,149
124,845
123,541
1,480,337
1,494,666
1,501,866
1,498,485
1,497,600
1,494,836
1,493,160
1,489,401
1,387,361
1,382,109
203,463
202,652
209,183
418,943
318,984
471,563
476,342
481,945
499,250
514,584
495,787
510,231
519,171
558,159
554,381
557,766
570,258
594,922
613,932
617,117
636,056
648,410
672,543
672,543648,410636,056617,117613,932594,922570,258557,766554,381558,159519,171510,231495,787514,584499,250481,945476,342471,563318,984418,943209,183202,652203,4631,382,1091,387,3611,489,4011,493,1601,494,8361,497,6001,498,4851,501,8661,494,6661,480,337123,541124,845126,149127,480127,32170,09770,72532,523110,65833,742105,39735,096102,31634,02899,18135,56197,62337,12280,05238,70483,44938,17642,9509,58726,4409,92927,09620,70116,894
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96,666
155,792
185,594
76,097
117,899
91,003
2,551,997
44,469
77,980
115,061
82,297
64,671
38,905
170,313
192,198
79,870
57,159
41,132
34,186
24,966
24,96634,18641,13257,15979,870192,198170,31338,90564,67182,297115,06177,98044,4692,551,99791,003117,89976,097185,594155,79296,666000000000000000000000000000000000000000000
> Total Liabilities 
84,343
113,786
91,628
94,160
97,260
134,899
107,951
145,097
133,718
182,139
196,611
192,255
300,248
357,474
355,921
424,446
400,784
415,194
414,862
443,249
434,124
516,399
510,968
572,986
667,575
684,854
737,116
638,606
651,655
1,182,701
1,286,418
1,014,259
1,415,866
1,242,662
1,156,260
1,004,306
924,695
919,622
892,456
983,242
809,337
907,609
919,911
1,158,400
1,111,262
1,356,247
2,002,467
2,498,728
2,655,480
2,787,758
2,963,000
2,819,546
3,570,857
3,654,921
3,565,368
3,614,316
3,676,581
4,167,772
3,971,412
3,725,951
3,497,032
2,967,269
2,967,2693,497,0323,725,9513,971,4124,167,7723,676,5813,614,3163,565,3683,654,9213,570,8572,819,5462,963,0002,787,7582,655,4802,498,7282,002,4671,356,2471,111,2621,158,400919,911907,609809,337983,242892,456919,622924,6951,004,3061,156,2601,242,6621,415,8661,014,2591,286,4181,182,701651,655638,606737,116684,854667,575572,986510,968516,399434,124443,249414,862415,194400,784424,446355,921357,474300,248192,255196,611182,139133,718145,097107,951134,89997,26094,16091,628113,78684,343
   > Total Current Liabilities 
84,336
110,349
87,020
84,612
87,712
120,378
93,030
128,610
116,835
173,090
187,401
158,589
264,141
267,577
265,605
341,547
317,774
338,072
338,015
378,672
368,762
474,807
468,337
549,311
640,871
660,647
713,780
617,546
632,149
1,140,653
1,245,218
973,462
1,370,461
1,203,227
1,117,310
963,677
884,327
874,783
846,788
937,396
759,865
836,848
852,525
1,061,008
1,015,074
1,232,626
1,826,673
2,235,207
2,203,763
2,340,014
2,077,850
1,762,570
1,986,426
2,058,256
2,032,795
2,242,005
2,284,884
2,677,905
2,381,682
2,103,079
1,856,127
1,564,848
1,564,8481,856,1272,103,0792,381,6822,677,9052,284,8842,242,0052,032,7952,058,2561,986,4261,762,5702,077,8502,340,0142,203,7632,235,2071,826,6731,232,6261,015,0741,061,008852,525836,848759,865937,396846,788874,783884,327963,6771,117,3101,203,2271,370,461973,4621,245,2181,140,653632,149617,546713,780660,647640,871549,311468,337474,807368,762378,672338,015338,072317,774341,547265,605267,577264,141158,589187,401173,090116,835128,61093,030120,37887,71284,61287,020110,34984,336
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
170,500
274,500
213,114
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000213,114274,500170,500000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
170,500
274,500
213,114
324,811
844,781
856,372
788,294
792,841
501,252
406,606
388,165
293,791
164,089
194,197
251,255
231,469
157,353
147,582
66,581
23,175
23,17566,581147,582157,353231,469251,255194,197164,089293,791388,165406,606501,252792,841788,294856,372844,781324,811213,114274,500170,500000000000000000000000000000000000000000000
       Accounts payable 
14,069
7,918
13,127
9,855
8,029
8,777
11,333
43,423
45,606
90,848
111,286
82,373
83,751
80,844
103,163
133,272
125,143
163,261
191,229
236,769
201,089
157,303
165,760
230,418
160,684
113,314
119,176
170,068
89,656
193,609
260,206
240,513
230,345
253,430
311,578
267,861
227,021
157,541
265,018
399,508
272,768
293,360
332,505
356,638
365,971
492,379
567,959
899,775
822,226
821,526
916,135
771,176
849,000
410,357
749,637
578,554
751,567
884,774
922,784
763,322
757,789
713,452
713,452757,789763,322922,784884,774751,567578,554749,637410,357849,000771,176916,135821,526822,226899,775567,959492,379365,971356,638332,505293,360272,768399,508265,018157,541227,021267,861311,578253,430230,345240,513260,206193,60989,656170,068119,176113,314160,684230,418165,760157,303201,089236,769191,229163,261125,143133,272103,16380,84483,75182,373111,28690,84845,60643,42311,3338,7778,0299,85513,1277,91814,069
       Other Current Liabilities 
23,477
55,391
55,883
56,777
61,703
108,831
78,927
82,417
68,459
82,242
61,615
53,216
152,390
153,733
118,062
157,455
127,631
111,911
101,786
95,903
108,673
254,604
199,677
213,493
310,787
351,432
413,704
270,078
461,546
635,418
663,386
429,823
567,873
453,189
404,264
295,816
357,305
446,853
309,769
169,572
267,348
197,728
341,144
328,411
429,108
232,734
400,704
306,994
580,836
424,879
624,810
332,129
629,142
679,635
861,672
637,727
758,481
77,745
69,095
617,262
57,777
23,659
23,65957,777617,26269,09577,745758,481637,727861,672679,635629,142332,129624,810424,879580,836306,994400,704232,734429,108328,411341,144197,728267,348169,572309,769446,853357,305295,816404,264453,189567,873429,823663,386635,418461,546270,078413,704351,432310,787213,493199,677254,604108,67395,903101,786111,911127,631157,455118,062153,733152,39053,21661,61582,24268,45982,41778,927108,83161,70356,77755,88355,39123,477
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
67,386
97,392
96,188
123,621
175,794
263,521
451,717
447,744
885,149
1,056,975
1,584,431
1,596,665
1,532,573
1,372,311
1,391,697
1,489,867
1,589,730
1,622,872
1,640,905
1,402,421
1,402,4211,640,9051,622,8721,589,7301,489,8671,391,6971,372,3111,532,5731,596,6651,584,4311,056,975885,149447,744451,717263,521175,794123,62196,18897,39267,386000000000000000000000000000000000000000000
       Other Liabilities 
0
3,437
4,608
9,548
9,548
14,486
14,447
15,785
15,872
3,277
3,172
7,916
7,812
11,274
11,844
11,728
11,953
20,995
21,133
23,810
24,582
19,233
20,441
20,144
23,257
20,806
20,024
17,818
16,241
33,956
33,220
31,935
36,592
35,640
35,090
37,033
36,792
41,375
42,407
45,845
49,472
70,761
67,386
67,392
66,188
78,621
78,234
80,831
106,577
85,714
88,861
87,142
89,677
71,501
69,880
68,293
66,717
0
0
87,941
0
0
0087,9410066,71768,29369,88071,50189,67787,14288,86185,714106,57780,83178,23478,62166,18867,39267,38670,76149,47245,84542,40741,37536,79237,03335,09035,64036,59231,93533,22033,95616,24117,81820,02420,80623,25720,14420,44119,23324,58223,81021,13320,99511,95311,72811,84411,2747,8127,9163,1723,27715,87215,78514,44714,4869,5489,5484,6083,4370
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
213,375
220,708
236,160
235,518
246,914
260,594
297,871
294,887
318,568
347,285
343,418
358,080
338,465
334,202
309,366
294,282
280,094
300,379
0
0
364,412
0
0
00364,41200300,379280,094294,282309,366334,202338,465358,080343,418347,285318,568294,887297,871260,594246,914235,518236,160220,708213,375000000000000000000000000000000000000000
> Total Stockholder Equity
21,275
61,127
125,512
152,838
177,878
926,879
940,876
933,995
966,256
1,008,860
1,028,268
1,026,828
926,366
967,773
1,006,690
1,050,754
1,118,956
1,376,011
1,437,109
1,516,214
1,604,407
1,690,616
1,931,578
2,069,657
2,209,505
2,345,814
3,379,325
3,488,121
3,679,841
5,269,278
5,402,782
5,577,760
5,741,639
5,929,499
6,064,542
6,180,982
6,346,982
6,351,513
6,514,203
6,637,675
6,759,980
6,405,108
6,562,221
6,737,254
6,915,189
6,786,377
6,905,996
6,974,461
7,217,273
7,194,121
7,390,823
7,514,826
7,717,410
7,772,889
8,009,981
8,011,074
8,143,563
8,290,277
8,462,630
8,552,710
8,714,157
8,710,064
8,710,0648,714,1578,552,7108,462,6308,290,2778,143,5638,011,0748,009,9817,772,8897,717,4107,514,8267,390,8237,194,1217,217,2736,974,4616,905,9966,786,3776,915,1896,737,2546,562,2216,405,1086,759,9806,637,6756,514,2036,351,5136,346,9826,180,9826,064,5425,929,4995,741,6395,577,7605,402,7825,269,2783,679,8413,488,1213,379,3252,345,8142,209,5052,069,6571,931,5781,690,6161,604,4071,516,2141,437,1091,376,0111,118,9561,050,7541,006,690967,773926,3661,026,8281,028,2681,008,860966,256933,995940,876926,879177,878152,838125,51261,12721,275
   Common Stock
36,300
36,300
36,300
37,752
37,752
50,342
50,342
100,684
100,684
100,684
100,684
151,026
151,026
151,026
151,026
226,539
226,539
249,315
249,315
373,972
373,972
373,972
382,020
574,141
574,141
574,096
607,688
911,532
911,532
1,004,814
1,004,454
1,004,454
1,003,799
3,011,396
3,011,055
3,011,055
3,011,055
3,011,055
3,011,055
3,011,055
3,011,055
3,011,055
3,011,055
3,011,055
3,011,055
3,005,705
3,005,705
3,005,705
3,004,155
3,004,155
3,004,155
3,004,155
3,004,155
3,004,155
3,004,155
3,004,155
3,004,155
0
0
3,004,155
0
0
003,004,155003,004,1553,004,1553,004,1553,004,1553,004,1553,004,1553,004,1553,004,1553,004,1553,005,7053,005,7053,005,7053,011,0553,011,0553,011,0553,011,0553,011,0553,011,0553,011,0553,011,0553,011,0553,011,0553,011,0553,011,3961,003,7991,004,4541,004,4541,004,814911,532911,532607,688574,096574,141574,141382,020373,972373,972373,972249,315249,315226,539226,539151,026151,026151,026151,026100,684100,684100,684100,68450,34250,34237,75237,75236,30036,30036,300
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000-44,255-44,255-44,255-44,255-95,180-95,18000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5,260
-668
-1,534
-4,220
-1,068
1,351
-20,901
-19,444
-24,891
-34,353
-36,427
-35,840
-38,031
-34,680
-19,977
-21,123
-13,829
371
0
0
8,159
0
0
008,15900371-13,829-21,123-19,977-34,680-38,031-35,840-36,427-34,353-24,891-19,444-20,9011,351-1,068-4,220-1,534-668-5,260000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,108,855
Cost of Revenue-2,803,387
Gross Profit3,305,4683,305,468
 
Operating Income (+$)
Gross Profit3,305,468
Operating Expense-5,468,297
Operating Income640,558-2,162,829
 
Operating Expense (+$)
Research Development215,587
Selling General Administrative2,121,609
Selling And Marketing Expenses0
Operating Expense5,468,2972,337,196
 
Net Interest Income (+$)
Interest Income19,311
Interest Expense-61,574
Other Finance Cost-5,853
Net Interest Income-48,116
 
Pretax Income (+$)
Operating Income640,558
Net Interest Income-48,116
Other Non-Operating Income Expenses0
Income Before Tax (EBT)606,823640,558
EBIT - interestExpense = -61,574
506,631
568,205
Interest Expense61,574
Earnings Before Interest and Taxes (EBIT)0668,397
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax606,823
Tax Provision-105,255
Net Income From Continuing Ops501,568501,568
Net Income506,631
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net048,116
 

Technical Analysis of Tianjin Chase Sun Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tianjin Chase Sun Pharmaceutical Co Ltd. The general trend of Tianjin Chase Sun Pharmaceutical Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tianjin Chase Sun Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tianjin Chase Sun Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.83 < 3.84 < 3.84.

The bearish price targets are: 3.07.

Tweet this
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tianjin Chase Sun Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tianjin Chase Sun Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current macd is -0.07482941.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tianjin Chase Sun Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tianjin Chase Sun Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tianjin Chase Sun Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current adx is 19.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tianjin Chase Sun Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tianjin Chase Sun Pharmaceutical Co Ltd. The current sar is 3.74874959.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current rsi is 39.85. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tianjin Chase Sun Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tianjin Chase Sun Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current cci is -96.02505941.

Tianjin Chase Sun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current cmo is -23.94554122.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tianjin Chase Sun Pharmaceutical Co Ltd. The current willr is -75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Tianjin Chase Sun Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Williams %R ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tianjin Chase Sun Pharmaceutical Co Ltd.

Tianjin Chase Sun Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current atr is 0.10032969.

Tianjin Chase Sun Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current obv is 626,472,937.

Tianjin Chase Sun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tianjin Chase Sun Pharmaceutical Co Ltd. The current mfi is 44.00.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tianjin Chase Sun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartTianjin Chase Sun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tianjin Chase Sun Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Tianjin Chase Sun Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tianjin Chase Sun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.848
Ma 20Greater thanMa 503.840
Ma 50Greater thanMa 1003.868
Ma 100Greater thanMa 2004.056
OpenGreater thanClose3.660
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tianjin Chase Sun Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tianjin Chase Sun Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tianjin Chase Sun Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tianjin Chase Sun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Tianjin Chase Sun Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tianjin Chase Sun Pharmaceutical Co Ltd.

Receive notifications about Tianjin Chase Sun Pharmaceutical Co Ltd in your mailbox!